CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis
Deep Dutta, Anshita Agarwal, Indira Maisnam, Rajiv Singla, Deepak Khandelwal, Meha Sharma
Endocrinol Metab. 2021;36(2):374-387.   Published online April 6, 2021
DOI: https://doi.org/10.3803/EnM.2020.818

Excel Download

Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis
Endocrinology and Metabolism. 2021;36(2):374-387   Crossref logo
Link1 Link2 Link3

Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy
Drug, Healthcare and Patient Safety. 2010;7   Crossref logo
Link1

PDB3 EFFICACY AND SAFETY OF DIPEPTIDYL-PEPTIDASE 4 [DPP 4] INHIBITORS IN TYPE 2 DIABETES: META-ANALYSIS
Value in Health. 2010;13(7):A283   Crossref logo
Link1 Link2

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
Diabetes, Obesity and Metabolism. 2013;15(6):523-530   Crossref logo
Link1 Link2

PDB10 A Meta-Analysis of Efficacy and Safety of Dipeptidyl Peptidase-4 [Dpp-4] Inhibitors in Type 2 Diabetes
Value in Health. 2012;15(4):A172   Crossref logo
Link1 Link2

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes
Diabetic Medicine. 2011;28(4):464-469   Crossref logo
Link1 Link2

Efficacy, safety and dose-response relationship of teneligliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus
Diabetes, Obesity and Metabolism. 2013;15(9):810-818   Crossref logo
Link1 Link2

Initial investigation of efficacy and safety of a new dipeptidyl peptidase-4 inhibitor, gosogliptin, for type 2 diabetes in Russia
Diabetes mellitus. 2014;17(4):81-86   Crossref logo
Link1 Link2

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes: Meta-Analysis
Annals of Pharmacotherapy. 2012;46(11):1453-1469   Crossref logo
Link1 Link2 Link3

Efficacy of Dipeptidyl Peptidase-4 Inhibitors on Leptin in type 2 Diabetes Mellitus: A Meta-Analysis
. 2021;   Crossref logo
Link1 Link2